Defining the limits: Protein aggregation and toxicity in vivo

Area of Science:

• Molecular Biology
• Cell Biology
• Neuroscience

Background:

• Cellular protein quality control (PQC) mechanisms, including molecular chaperones and proteolytic degradation, normally maintain proteome homeostasis.
• Disruptions from environmental, genetic, or stochastic factors can overwhelm PQC, causing protein misfolding, aggregation, and cellular toxicity.
• Neurodegenerative diseases, such as Huntington's Disease, are linked to expanded polyglutamine tracts and protein aggregation, highlighting the need to understand these processes.

Purpose of the Study:

• To investigate the mechanistic links between protein misfolding, aggregation, and toxicity in the context of neurodegenerative diseases.
• To explore the complexity of protein aggregation pathways and the role of PQC processes in model systems.
• To determine the critical factors underlying the molecular basis of protein aggregate toxicity.

Main Methods:

• Utilized yeast (Saccharomyces cerevisiae) and other model systems to study protein aggregation pathways.
• Examined the interplay between protein quality control processes and aggregate formation.
• Analyzed cellular perturbations resulting from protein misfolding and aggregation.

Main Results:

• Uncovered significant complexity in protein aggregation pathways and their relationship with PQC.
• Demonstrated that cellular PQC pathways can be overwhelmed by protein misfolding events.
• Identified aggregate interactions and cellular localization as critical determinants of toxicity, rather than aggregate size.

Conclusions:

• Protein misfolding and aggregation are key contributors to pathogenesis in diseases like Huntington's Disease.
• Aggregate interactions and localization are more critical than aggregate size in determining molecular toxicity.
• Further research into these interactions and localization is essential for understanding neurodegenerative disease mechanisms.